THE 60 GY IN 3 TO 5 FRACTIONS RECOMMENDATION FOR STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR STAGE I NON-SMALL CELL LUNG CANCER (NSCLC) IS OVERKILL: A PLEA FOR A INDIVIDUALISED DOSE PRESCRIPTION

被引：0
|
作者：
De Ruysscher, D. [1 ]
van Baardwijk, A. [2 ]
Tome, W. [3 ]
Bentzen, S. [3 ]
Wanders, S. [2 ]
Reymen, B. [2 ]
Borger, J. [2 ]
van Elmpt, W. [2 ]
Ollers, M. [2 ]
Lambin, P. [2 ]
机构：
[1] MUCM, Maastricht, Netherlands
[2] MAASTRO Clin, Maastricht, Netherlands
[3] Univ Wisconsin, Sch Med & Publ H, Madison, WI USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页码：S356 / S357
页数：2
相关论文
共 50 条
  • [21] Changes in Volumes of Stage I Non-small Cell Lung Cancer (NSCLC) During Stereotactic Body Radiation Therapy (SBRT)
    Tatekawa, K.
    Iwata, H.
    Kawaguchi, T.
    Baba, F.
    Otsuka, S.
    Miyakawa, A.
    Iwana, M.
    Tamura, T.
    Shibamoto, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S576 - S577
  • [22] Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC)
    Janssen, Stefan
    Kaesmann, Lukas
    Rudat, Volker
    Rades, Dirk
    LUNG, 2016, 194 (02) : 291 - 294
  • [23] Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC)
    Stefan Janssen
    Lukas Kaesmann
    Volker Rudat
    Dirk Rades
    Lung, 2016, 194 : 291 - 294
  • [24] Stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC)
    Dahele, M.
    Pearson, S.
    Franks, K.
    Purdie, T.
    Bissonnette, J.
    Brade, A. M.
    Cho, J.
    Sun, A.
    Jaffray, D.
    Bezjak, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Stereotactic radiotherapy in stage I non-small cell lung cancer
    Fleckenstein, J.
    Ruebe, C.
    ONKOLOGE, 2018, 24 (12): : 967 - 973
  • [26] Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
    Okoye, Christian C.
    Cho, C. Jane
    Liu, Mitchell
    Louie, Alexander V.
    Obayomi-Davies, Olusola
    Siva, Shankar
    Lo, Simon S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (18)
  • [27] VALIDITY OF SPECIFIC GROWTH RATE IN STAGE I NON-SMALL CELL LUNG CANCER TREATED WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT)
    Atallah, Soha
    Cook, Graham
    MacRae, Robert
    Cross, Peter
    Bezjak, Andrea
    Hope, Andrew J.
    Pantarotto, Jason
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S86 - S86
  • [28] Stereotactic Body Radiotherapy (SBRT) for Non-small Cell Lung Cancer (NSCLC) -is FDG-PET a Predictor of Outcome?
    Clarke, K. L.
    Taremi, M.
    Freeman, M.
    Fung, S.
    Dahele, M.
    Bezjak, A.
    Brade, A.
    Cho, J.
    Hope, A.
    Sun, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S499 - S500
  • [29] Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer
    Bang, Andrew
    Bezjak, Andrea
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (01) : 58 - 69
  • [30] Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): Solid evidence or "no-go"?
    Nestle, Ursula
    Faivre-Finn, Corinne
    DeRuysscher, Dirk
    Hurkmans, Coen
    Guckenberger, Matthias
    Belderbos, Jose
    le Pechoux, Cecile
    RADIOTHERAPY AND ONCOLOGY, 2013, 109 (01) : 178 - 179
12345